IP Library Granted Patent US 9,061,056
Granted Patent B2
US 9,061,056 · App. 13/219,514 · Granted Jun 23, 2015

Compositions and methods for targeted thermomodulation

Inventors: Todd James Harris (San Clemente, CA); Alice Ann Chen (San Francisco, CA)
Assignee: Sienna Labs, Inc.
A61K41/0052A61K8/0245A61K8/0283A61K8/29A61K2800/413A61K2800/621A61K2800/624A61K2800/81A61Q9/04A61Q19/06A61Q19/08A61K9/0009A61K9/0014A61K9/5115A61B17/50A61B18/203A61N5/0617A61N5/0616B82Y5/00A61N5/062A61K9/009A61B18/06A61B18/18A61B2018/0047A61B2018/00476A61B2018/00577A61B2018/068A61B2018/00452A61K8/11A61K9/5123A61K9/5146A61K9/5153A61K41/0057A61K2800/622A61Q9/00A61Q19/00A61N2005/067
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,061,056
App. No.
13/219,514
Granted
Jun 23, 2015
Kind
B2
Abstract

Provided are nanoparticles and formulations which are useful for cosmetic, diagnostic and therapeutic applications to mammals such as humans.

Claims (76)

1. A topical cosmetic composition comprising:

a cosmetically acceptable carrier;

wherein the cosmetically acceptable carrier is configured for topical administration; and

a plurality of plasmonic nanoplates with a concentration of 10 11 to 10 23 particles per ml of composition,

wherein the plasmonic nanoplates comprise at least one conductive metal selected from the group consisting of silver, gold, nickel, copper, titanium, silicon, galadium, palladium, platinum, and chromium,

wherein the plasmonic nanoplates have a size in a range of 10 nm to 300 nm,

wherein the plasmonic nanoplates comprise a coating that coats the conductive metal,

wherein the coating comprises silica or polyethylene glycol (PEG),

wherein said coating is configured for distributing the plasmonic nanoplates to a target tissue region and for facilitating removal of the plasmonic nanoplates from a skin surface,

wherein the plasmonic nanoplates have a peak absorption wavelength of between 750 nm and 1200 nm,

wherein the plasmonic nanoplates, upon irradiation with an infrared light source in a range of 750 nm to 1200 nm, induce thermal damage in the target tissue region with which the composition is topically contacted.

2. The composition of claim 1 , wherein plasmonic nanoplates are activated by exposure to energy delivered from a nonlinear excitation surface plasmon resonance source to the target tissue region.

3. The composition of claim 1 , wherein the plasmonic nanoplates comprise at least one of the group consisting of a metallic composite, a metal oxide, a metallic salt, an electric conductor, an electric superconductor, an electric semiconductor, a dielectric, and a composite from a combination thereof.

4. The composition of claim 1 , wherein the plasmonic nanoplates have an optical density of 10 O.D. to 5,000 O.D. within the infrared.

5. The composition of claim 1 , wherein the plasmonic nanoplates comprise a silica coating with a thickness of 5 to 35 nanometers.

6. The composition of claim 1 , wherein the metal is silver and the coating is silica, and the nanoplates consist of said silver coated by said silica.

7. The composition of claim 1 , wherein the cosmetically acceptable carrier comprises at least one of the group consisting of an additive, a colorant, an emulsifier, a fragrance, a humectant, a polymerizable monomer, a stabilizer, a solvent, and a surfactant.

8. The composition of claim 7 , wherein the surfactant is selected from the group consisting of: sodium laureth 2-sulfate, sodium dodecyl sulfate, ammonium lauryl sulfate, sodium octech-1/deceth-1 sulfate, lipids, proteins, and peptides.

9. The composition of claim 7 , comprising surfactant in an amount between 0.1 and about 10.0% weight-to-weight of the carrier.

10. The composition of claim 7 , wherein the solvent is selected from the group consisting of water, propylene glycol, alcohol, hydrocarbon, chloroform, acetic acid, formic acid, base, acetone, diethyl-ether, dimethyl sulfoxide, dimethylformamide, acetonitrile, tetahydrofuran, dichloromethane, and ethylacetate.

11. The composition of claim 1 , wherein the plasmonic nanoplates have an optical density of at least 100 O.D. at one or more peak resonance wavelengths.

12. The composition of claim 1 , wherein the plasmonic nanoplates comprise a hydrophilic or aliphatic coating, wherein the coating comprises at least one of the group consisting of polyethylene glycol, silica, silica-oxide, polyvinylpyrrolidone, polystyrene, a protein and a peptide.

13. The composition of claim 1 , wherein the thermal damage is comprises at least one of the group consisting of thermomodulation, ablation, lysis, denaturation, induction of inflammation, activation of heat shock proteins, perturbation of cell-signaling and disruption to a cell microenvironment in the target tissue region.

14. The composition of claim 1 , wherein the target tissue region comprises at least one of the group consisting of a skin surface, an epidermis, a dermis, a pilosebaceous unit, a sebaceous gland, a component of a sebaceous gland, a sebocyte, a component of a sebocyte, a sebum, and a hair follicle infundibulum.

15. The composition of claim 1 , wherein the target tissue region comprises at least one of the group consisting of a bulge, a bulb, a stem cell, a stem cell niche, a dermal papilla, a cortex, a cuticle, a hair sheath, a medulla, a pylori muscle, a Huxley layer, or and a Henle layer.

16. A topical cosmetic composition, comprising:

a plurality of plasmonic nanoplates comprising a solid, conducting metal core and a coating,

wherein the coating comprises at least one of silica and polyethylene glycol that coats the conducting metal core,

wherein the coating is configured for distributing the plasmonic nanoplates to a target tissue region and for facilitating removal of the plasmonic nanoplates from a skin surface,

wherein the conducting metal core comprises at least one selected from the group consisting of silver and gold,

wherein the plasmonic nanoplates have a concentration of 10 11 to 10 23 particles per ml of composition,

wherein the plasmonic nanoplates have a size in a range of 10 nm to 300 nm,

wherein the plasmonic nanoplates have a peak absorption wavelength of between 750 nm and 1200 nm,

wherein the plasmonic nanoplates, upon irradiation with an infrared light source in a range of 750 nm to 1200 nm, induce thermal damage in the target tissue with which the plasmonic nanoplates are topically contacted; and

a cosmetically acceptable carrier configured for topical administration.

17. The composition of claim 16 , wherein the plasmonic nanoplates have an optical density of 10 O.D. to 5,000 O.D.

18. The composition of claim 16 , wherein the plasmonic nanoplates have a peak absorption wavelength of between 750 nm and 1200 nm.

19. The composition of claim 16 , wherein the plasmonic nanoplates have a linear dimension of 10-200 nm.

20. The composition of claim 16 , wherein the silica has a thickness of 5 to 35 nanometers.

21. The composition of claim 16 , wherein the cosmetically acceptable carrier comprises at least one of the group consisting of an additive, a colorant, an emulsifier, a fragrance, a humectant, a polymerizable monomer, a stabilizer, a solvent, and a surfactant.

22. The composition of claim 16 , wherein the acceptable carrier comprises water and propylene glycol.

23. A topical cosmetic composition for treating skin, comprising:

a plurality of plasmonic nanoplates comprising a conductive metal portion and a coating,

wherein the conductive metal portion comprises at least one of gold, silver, nickel, platinum, and titanium,

wherein the coating comprises one or more of silica and polyethylene glycol (PEG),

wherein the coating is configured for distributing the plasmonic nano slates to a target tissue region and for facilitating removal of the plasmonic nano slates from a skin surface,

wherein the plasmonic nanoplates have a concentration of 10 11 to 10 23 particles per ml of composition,

wherein the plasmonic nanoplates have a peak absorption wavelength of between 750 nm and 1200 nm,

wherein the plasmonic nanoplates, upon irradiation with an infrared light source in a range of 750 nm to 1200 nm, induce thermal damage in the target tissue with which the plasmonic nanoplates are topically contacted,

wherein the plasmonic nanoplates have a linear dimension of 10 nm to 300 nm,

wherein the plasmonic nanoplates comprise a shape selected from the group consisting of an oval, a square, a rectangle, and a triangle

wherein the target tissue comprises a pilosebaceous unit; and

a cosmetically acceptable carrier configured for topical administration to the skin.

24. The composition of claim 23 , wherein the plasmonic nanoplates have an optical density of 10 O.D. to 5,000 O.D, and wherein the metal portion is silver and the coating is silica, and wherein the nanoplates consist of said silver coated by said silica.

25. The composition of claim 23 ,

wherein the cosmetically acceptable carrier comprises at least one of the group consisting of an additive, a colorant, an emulsifier, a fragrance, a humectant, a polymerizable monomer, a stabilizer, a solvent, and a surfactant,

wherein the surfactant is selected from the group consisting of: sodium laureth 2-sulfate, sodium dodecyl sulfate, ammonium lauryl sulfate, sodium octech-1/deceth-1 sulfate, lipids, proteins, and peptides,

wherein the metal portion is silver and the coating is silica, and

wherein the nanoplates consist of said silver coated by said silica.

26. A topical cosmetic composition comprising:

a cosmetically acceptable carrier;

wherein the cosmetically acceptable carrier is configured for topical administration to a skin surface; and

a plurality of plasmonic nanoparticles with a concentration of 10 11 to 10 23 particles per ml of composition,

wherein the plasmonic nanoparticles are in unassembled form,

wherein the plasmonic nanoparticles comprise at least one conductive metal selected from the group consisting of silver and gold,

wherein the plasmonic nanoparticles comprise a coating that coats the conductive metal,

wherein the coating comprises silica or polyethylene glycol (PEG),

wherein said coating is configured for distributing the plasmonic nanoparticles to a tar et tissue region and for facilitating removal of the plasmonic nanoparticles from the skin surface,

wherein the plasmonic nanoparticles have at least one dimension in a range of 10 nm to 300 nm,

wherein the plasmonic nanoparticles have a peak absorption wavelength of between 750 nm and 1200 nm,

wherein the plasmonic nanoparticles, upon irradiation with an infrared light source in a range of 750 nm to 1200 nm, induce thermal damage in a target tissue region with which the composition is topically contacted.

27. The topical cosmetic composition of claim 26 ,

further comprising a surfactant,

wherein the conductive metal is silver,

wherein the coating is silica, and

wherein the plasmonic nanoparticles consist of said silver coated by said silica.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2022
From: HERCULES TECHNOLOGY MANAGEMENT CO IV, LLC
To: CORONADO AESTHETICS, LLC
Reel/Frame 059763/0794 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2022
From: SEBACIA, INC.
To: HERCULES TECHNOLOGY MANAGEMENT CO IV, LLC
Reel/Frame 059750/0939 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2020
From: SIENNA BIOPHARMACEUTICALS, INC.
To: SEBACIA, INC.
Reel/Frame 052138/0380 →
ASSIGNEE CHANGE OF ADDRESS Recorded Feb 17, 2017
From: SIENNA BIOPHARMACEUTICALS, INC.
To: SIENNA BIOPHARMACEUTICALS, INC.
Reel/Frame 041746/0955 →
CHANGE OF NAME Recorded Mar 2, 2016
From: SIENNA LABS, INC.
To: SIENNA BIOPHARMACEUTICALS, INC.
Reel/Frame 037977/0634 →
ASSIGNEE CHANGE OF ADDRESS Recorded Oct 8, 2015
From: SIENNA LABS, INC.
To: SIENNA LABS, INC.
Reel/Frame 036819/0344 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2011
From: HARRIS, TODD JAMES; CHEN, ALICE ANN
To: SIENNA LABS, INC.
Reel/Frame 027095/0095 →
Continuity (4)
Provisional Application 61402305 · Aug 27, 2010
Provisional Application 61422612 · Dec 13, 2010
Provisional Application 61516308 · Apr 1, 2011
Related Publication 20120059307A1 · Mar 8, 2012